{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:00:24Z","timestamp":1792270824806,"version":"4.4.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.ygyno.2009.10.071","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T14:46:50Z","timestamp":1258555610000},"page":"332-334","source":"Crossref","is-referenced-by-count":30,"title":["A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study"],"prefix":"10.1016","volume":"116","author":[{"given":"Thomas F.","family":"Rocereto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Rotmensch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Mannel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2009.10.071_bib1","series-title":"Principles and practice of gynecologic oncology","first-page":"295","article-title":"Epithelial ovarian cancer","author":"Ozols","year":"2005"},{"key":"10.1016\/j.ygyno.2009.10.071_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2009.10.071_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatinum and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2009.10.071_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/edrv-12-1-14","article-title":"Endocrine factors in common epithelial ovarian cancer","volume":"12","author":"Rao","year":"1991","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ygyno.2009.10.071_bib5","first-page":"999","article-title":"Response of human ovarian carcinoma cell lines to antiprogestin mifepristone","volume":"12","author":"Rose","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2009.10.071_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/gyno.2000.5789","article-title":"Phase II study of mifepristone (RU486) in refractory ovarian cancer","volume":"77","author":"Rocereto","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.10.071_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2009.10.071_bib8","unstructured":"Sill, M.W., Yothers, G. A method for utilizing bivariate efficacy outcome measures to screen agents for activity in the 2-stage phase II clinical trials, Technical Report 06-08, Department of Biostatistics, University of Buffalo. Website: http:\/sphhp.buffalo.edu\/biostat\/research\/techreports\/index.php."},{"key":"10.1016\/j.ygyno.2009.10.071_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809008907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809008907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T05:20:52Z","timestamp":1544851252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825809008907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0090825809008907"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2009.10.071","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}